- Home
- ASG vs CATX Comparison
ASG vs CATX Comparison
Compare ASG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASG
- CATX
- Stock Information
- Founded
- ASG 1986
- CATX 1983
- Country
- ASG United States
- CATX United States
- Employees
- ASG N/A
- CATX N/A
- Industry
- ASG Investment Managers
- CATX Medical/Dental Instruments
- Sector
- ASG Finance
- CATX Health Care
- Exchange
- ASG Nasdaq
- CATX Nasdaq
- Market Cap
- ASG 295.0M
- CATX 239.0M
- IPO Year
- ASG N/A
- CATX N/A
- Fundamental
- Price
- ASG $5.20
- CATX $3.44
- Analyst Decision
- ASG
- CATX Strong Buy
- Analyst Count
- ASG 0
- CATX 10
- Target Price
- ASG N/A
- CATX $13.00
- AVG Volume (30 Days)
- ASG 324.3K
- CATX 1.5M
- Earning Date
- ASG 01-01-0001
- CATX 08-11-2025
- Dividend Yield
- ASG 8.09%
- CATX N/A
- EPS Growth
- ASG N/A
- CATX N/A
- EPS
- ASG N/A
- CATX N/A
- Revenue
- ASG N/A
- CATX $1,471,000.00
- Revenue This Year
- ASG N/A
- CATX N/A
- Revenue Next Year
- ASG N/A
- CATX N/A
- P/E Ratio
- ASG N/A
- CATX N/A
- Revenue Growth
- ASG N/A
- CATX N/A
- 52 Week Low
- ASG $4.47
- CATX $1.60
- 52 Week High
- ASG $5.71
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- ASG 55.94
- CATX 60.53
- Support Level
- ASG $5.22
- CATX $2.96
- Resistance Level
- ASG $5.34
- CATX $3.77
- Average True Range (ATR)
- ASG 0.07
- CATX 0.41
- MACD
- ASG -0.02
- CATX 0.02
- Stochastic Oscillator
- ASG 57.86
- CATX 73.78
About ASG Liberty All-Star Growth Fund Inc.
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.